The French industrial gas giant today said it’s broadening its services for diabetes patients in Germany, Belgium, the Netherlands and Luxembourg.
Medical device manufacturer Tandem Diabetes Care will provide Air Liquide patients in Germany and Benelux with state-of-the-art insulin pumps as part of its services offer.
The insulin pump, combined with a continuous glucose monitoring system, makes it possible to anticipate the risks of hypoglycaemia and automatically suspend the delivery of insulin, facilitating the use of the pump on a daily basis, Air Liquide said.
Air Liquide is already a partner of Tandem Diabetes Care in other European countries.
François Jackow, Executive Vice-President and member of the Air Liquide Executive Committee supervising in particular the Healthcare world business line, said, “Air Liquide continues to develop its home healthcare offer in Europe to meet the growing needs of patients with complex chronic diseases.”
“With more than 30 years of experience, the group provides patients with an offer combining the most recent technological and digital innovations with personalised patient support.”
“Air Liquide thus continues its commitment to contribute to improving the quality of life of more than 1.6 million patients worldwide.”